Cargando…
Src-like adaptor protein 2 (SLAP2) binds to and inhibits FLT3 signaling
Fms-like tyrosine kinase (FLT3) is a frequently mutated oncogene in acute myeloid leukemia (AML). FLT3 inhibitors display promising results in a clinical setting, but patients relapse after short-term treatment due to the development of resistant disease. Therefore, a better understanding of FLT3 do...
Autores principales: | Moharram, Sausan A., Chougule, Rohit A., Su, Xianwei, Li, Tianfeng, Sun, Jianmin, Zhao, Hui, Rönnstrand, Lars, Kazi, Julhash U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295388/ https://www.ncbi.nlm.nih.gov/pubmed/27458164 http://dx.doi.org/10.18632/oncotarget.10760 |
Ejemplares similares
-
SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation
por: Rupar, Kaja, et al.
Publicado: (2018) -
Src-Like Adaptor Protein (SLAP) Binds to the Receptor Tyrosine Kinase Flt3 and Modulates Receptor Stability and Downstream Signaling
por: Kazi, Julhash U., et al.
Publicado: (2012) -
Expression of GADS enhances FLT3-induced mitogenic signaling
por: Chougule, Rohit A., et al.
Publicado: (2016) -
Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD
por: Kazi, Julhash U., et al.
Publicado: (2017) -
ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling
por: Kazi, Julhash U., et al.
Publicado: (2017)